Manorama Industries Limited is a specialized manufacturer of exotic fats and butters, catering primarily to the global chocolate, confectionery, and cosmetic industries. The company has established a strong market position through a fully integrated value chain, which spans from the direct sourcing of raw materials like shea, mango, and other exotic seeds from forests in India and West Africa to advanced research and development and high-tech manufacturing processes. This backward-integrated model provides significant control over quality, cost, and supply stability, creating a defensible competitive advantage. Manorama operates in a structurally undersupplied, high-growth niche market, focusing on producing value-added products such as Cocoa Butter Equivalents (CBE), specialty fats, and stearin. The business model is technology and formulation-driven, allowing the company to build long-term, application-specific relationships with its worldwide customer base, making it less susceptible to commodity price volatility. With a commitment to operational excellence and strategic capacity expansions, the company is positioned to capitalize on the increasing global demand for sustainable and high-quality specialty ingredients.

Official Website: http://www.manoramagroup.co.in/

• Q3 FY26 Performance: The company reported a revenue of INR 363 crores. EBITDA stood at INR 98 crores with a margin of 27.1%, and Profit After Tax (PAT) was INR 68 crores, reflecting a margin of 18.8%.

• 9M FY26 Performance: For the nine months ending December 31, 2025, revenue was INR 975 crores, an 81.3% year-on-year growth. EBITDA for this period was INR 265 crores with a margin of 27.2%, while PAT was INR 174 crores with a margin of 17.8%.

• Revenue Guidance: In light of strong performance and steady demand, the revenue guidance for the full financial year 2026 has been upwardly revised from INR 1,150 crores to INR 1,300 crores.

• Other Income: The significant increase in other income during the third quarter was attributed to foreign exchange gains on the import of raw materials like shea nuts.

• Employee Expenses: Employee costs decreased during the quarter because the company completed the process of granting ESOPs, and further provisions were not required.

The company has demonstrated robust financial performance with significant year-on-year revenue growth and stable, high-profitability margins, leading to an upward revision of its annual revenue guidance.

• Integrated Value Chain: Manorama operates a backward-integrated model, controlling the entire process from raw material procurement to final product manufacturing. This ensures unparalleled control over quality, supply chain stability, and costs.

• Technology-Driven Model: The business is not a commodity play. It is driven by advanced R&D, specialized fat blending, and fractionation technology to create customized, high-value products like Cocoa Butter Equivalents (CBE).

• Pricing Power: The company's pricing is based on a cost-plus margin model and is not directly linked to the volatile prices of commodities like cocoa butter. This is due to its different raw material base and the technical, solution-oriented nature of its products.

• Customer Stickiness: Manorama develops products based on specific customer applications and formulations. This technical integration fosters long-term customer loyalty, as clients are less likely to switch suppliers.

The company's defensible moat is built on its integrated model, technology-led product development, and stable pricing power, which insulates it from commodity cycles and fosters deep customer relationships.

• Market Structure: The company operates in a structurally undersupplied and high-growth niche market for exotic specialty fats and butters.

• Commodity Volatility: Management asserts that its business is not impacted by the volatility in cocoa butter prices. Their raw materials, product formulations, and pricing models are fundamentally different from those of commodity cocoa butter.

• EU Deforestation Regulations: The company does not anticipate any impact from EU deforestation rules, as its raw materials are sourced as forest waste products and do not involve farming or deforestation activities, unlike commodities such as cocoa beans.

The company is well-positioned within a high-growth niche market and is structurally insulated from key industry pressures like commodity price fluctuations and new environmental regulations.

• Primary Growth Driver: The 73.3% year-on-year revenue growth in Q3 FY26 was primarily driven by volume increases. For the nine-month period, approximately 90% of the growth was attributed to higher volumes, resulting from the utilization of newly added capacity.

• Future Growth Visibility: Management has a clear growth plan for the next 4-5 years, supported by both the debottlenecking of existing facilities and the commissioning of a major new capex plan.

• Value-Added Focus: A key growth strategy is to increase the sales contribution of value-added products from the current level of 75% to a target of 85-90% in the coming years.

• FY27 Outlook: The company anticipates continued strong growth, projecting a revenue increase of approximately 30% or more for the next financial year, driven by capacity enhancements.

Growth is being propelled by strong volume uptake from recent capacity additions, with a clear and sustained growth trajectory planned through further expansion and an increasing focus on high-value products.

• New Product Development: The company is entering the Cocoa Butter Alternatives (CBA) market through a new process called ESOS (enzymatic stearin-oleic-stearic). This process converts soft fractions like olein into valuable hard fats, diversifying the product portfolio and raw material base.

• Geographical Expansion: Strategic investments in a processing factory in Burkina Faso, West Africa, and a partnership with the Dekel Group in Latin America are set to expand the company's global manufacturing footprint and provide access to key international markets.

• Working Capital Optimization: The new ESOS process for CBA will utilize the company's own olein (a byproduct) as a raw material, significantly reducing the working capital cycle for this new product line to 1-3 months compared to the current 5-6 months.

The company is actively pursuing significant growth opportunities through new product innovation, strategic international expansion, and operational efficiencies that enhance its business model.

• Current Utilization: The existing facilities are operating at approximately 85% capacity utilization, indicating strong demand.

• Immediate Expansion (Debottlenecking): The company is increasing its current fractionation capacity by 30%, from 40,000 MTPA to 52,000 MTPA. This debottlenecking is expected to be completed by the end of FY26.

• Major Capex Plan: A substantial capital expenditure of INR 460 crores is planned over the next 2-3 years, funded primarily through internal accruals. The plan includes:

• 75,000 MTPA facility for Cocoa Butter Alternatives (CBA).

• 75,000 MTPA new fractionation facility.

• 90,000 MTPA new refinery.

• 90,000 MTPA processing factory in Burkina Faso, West Africa.

• Asset Turnover: The forward integration projects are expected to generate an asset turnover of more than 5x, indicating high capital efficiency.

The company is executing a well-defined, multi-pronged expansion strategy, combining immediate debottlenecking with a large-scale, long-term capex plan to meet future demand.

• Capex Timeline: The new capacities from the INR 460 crore investment will be commissioned in a phased manner, with all projects expected to be operational by FY28.

• Strategic Raw Material Diversification: The new projects, particularly the ESOS process, are designed to diversify the raw material base away from a sole reliance on exotic seeds. This will involve the captive consumption of olein and the use of other soft oils.

• Product Portfolio Enhancement: The overall goal of the expansion is to increase the total output of high-value stearin-based fats and CBE/CBA, strengthening the company's product portfolio and market leadership.

The company's future plans are centered on a strategic, phased capacity expansion that diversifies its raw material base and significantly scales up its production of high-value specialty fats.

• EBITDA Margin: The company maintains a stable and sustainable EBITDA margin in the range of 25% to 27%. The margin for 9M FY26 was 27.2%.

• Gross Margin: Gross margins typically range from 45% to 50%, with fluctuations caused by factors like freight costs and byproduct realization. These fluctuations do not materially impact the final EBITDA margin.

• Future Margin Outlook: While the current margin level is considered sustainable, management aims to improve it over the medium to long term. The new forward and backward integration projects are expected to contribute positively to margin enhancement.

• New Product Margins: The upcoming CBA product line is not expected to be margin dilutive. The company is targeting margins that are similar to or better than those of its existing business.

The company has successfully maintained high and stable EBITDA margins and expects that future projects and a richer product mix will help sustain or improve this profitability.

• Working Capital Cycle: The current working capital cycle is 120 days on sales. This is expected to improve and settle in the 90-100 day range once the new capacities, which require less inventory holding, are operational.

• Partnership Progress: The partnership with the Dekel Group has started generating revenue, with an expected delivery of over 2,000 tons in the current financial year.

• Infrastructure Development: The company has acquired 19.40 acres of land adjacent to its existing facility and has already commissioned a new packing plant and laboratory building, all funded via internal accruals.

• Product Mix: Value-added products currently constitute approximately 75% of total sales, with CBE's contribution at around 30%.

The company is actively managing its working capital, operationalizing its international partnerships, and investing in supporting infrastructure to facilitate its ongoing growth.